Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
News
Michelle L. Litchman Focuses On Diabetes Program Accessibility For People Who Are Deaf
Michelle L. Litchman was named a Betty Irene Moore Nurse Fellow. She will focus on diabetes program accessibility for people who are deaf.
Omnipod 5 Pivotal Trial Data Published
Data from the pivotal trial shows that the Omnipod 5 improves time-in-range, and reduces HbA1c and mean glucose levels.
Breaking News From ATTD 2021
This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.
Survey Finds the Pandemic Increased Mental Health Concerns Among People With Diabetes
Cecelia Health conducted a survey that revealed increased mental health concerns among people with diabetes during the COVID-19 pandemic.
Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace
Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.
Bigfoot Unity™ Diabetes Management System Receives The Green Light From The FDA
Bigfoot Unity™, a one-of-a-kind diabetes management system with smart pen caps received FDA approval on May 10, 2021 and will reach select diabetes clinics this spring.
Asian Isn’t A Monolith: Why More Specific Data Matters in Diabetes Research
Data on how diabetes impacts specific ethnic groups could help us better support people within Asian American Pacific Islander communities.
The PROTECT Study
The PROTECT Study aims to understand how the investigational medicine, teplizumab, works in children and young adults who have recently been diagnosed with T1D, as well as assessing if there are any s...
Chris Hahm’s Uphill Battle: The Severe Underfunding of AAPI Diabetes Research
H. Chris Hahm shares her challenges of conducting diabetes research focused on the AAPI community, research that is severely underfunded.
CDC and FDA Call for Pause on Johnson & Johnson Vaccine
After six cases of rare blood clots, the CDC and FDA has advised healthcare professionals to pause on distributing the Johnson and Johnson vaccine.
FDA Approves New Glucagon Option from Zealand Pharma
Available in June 2021, the FDA approved Zealand Pharma’s Zeagalogue, a new form of glucagon for people with insulin-dependent diabetes.
Don’t Have Health Insurance Right Now? Read This
You may qualify for subsidies that lower the cost of your insurance; here's what you need to know to pick a Healthcare.gov plan for 2022.
JDRF Announces New Center of Excellence to Advance T1D Research
On February 23, 2021, JDRF announced the launch of the JDRF Center of Excellence in collaboration with the Harvard Stem Cell Institute in New England.
Inside the Senate Report on Rising Insulin Prices
A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.
Get the Facts on Insulin Pricing + The Presidential Transition
A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin.
Posts navigation
←
Newer
Posts
1
…
3
4
5
…
11
Older
Posts
→